MILPRAZON 16 MG/40 MG FILM-COATED TABLETS FOR CATS WEIGHING AT LEAST 2 KG

국가: 아일랜드

언어: 영어

출처: HPRA (Health Products Regulatory Authority)

유효 성분:

MILBEMYCIN OXIME, PRAZIQUANTEL

제공처:

Krka, d.d., Novo mesto

ATC 코드:

QP54AB51

INN (국제 이름):

MILBEMYCIN OXIME, PRAZIQUANTEL

복용량:

16.0/40.0

약제 형태:

Film Coated Tablet

처방전 유형:

POM

치료 그룹:

Feline

치료 영역:

Milbemycin, combinations

치료 징후:

Endoparasiticide

승인 상태:

Authorised

승인 날짜:

2015-05-01

제품 특성 요약

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Milprazon 16 mg/40 mg film-coated tablets for cats weighing at least 2 kg
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each film-coated tablet contains:
For the full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Film-coated tablet.
Brown red, oval, biconvex film-coated tablets with score line on one side.
The tablets can be divided into equal halves.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats (weighing at least 2 kg).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In cats: treatment of mixed infections by immature and adult cestodes and nematodes of the following species:
- Cestodes:
_Dipylidium caninum_
_Taenia _spp.
_Echinococcus multilocularis_
- Nematodes:
_Ancylostoma tubaeforme_
_Toxocara cati_
Prevention of heartworm disease (_Dirofilaria immitis_) if concomitant treatment against cestodes is indicated.
4.3 CONTRAINDICATIONS
Do not use in cats weighing less than 2 kg.
Do not use in cases of hypersensitivity to the active substances or to any of the excipients.
ACTIVE SUBSTANCES:
Milbemycin oxime
16
mg
Praziquantel
40
mg
EXCIPIENTS:
Iron Oxide, red (E172)
0.20 mg
Titanium dioxide (E171) 0.51 mg
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 24/11/2016_
_CRN 7025057_
_page number: 1_
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
It is recommended to treat all the animals living in the same household concomitantly.
In order to develop an effective worm control programme local epidemiological information and the risk of exposure of
the cat should be taken into account.
When _D. caninum _infection is present, concomitant treatment against intermediate hosts, such as fleas and lice, should
be